{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:23:52Z","timestamp":1789741432998,"version":"4.0.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.critrevonc.2016.03.006","type":"journal-article","created":{"date-parts":[[2016,3,6]],"date-time":"2016-03-06T01:37:21Z","timestamp":1457228241000},"page":"169-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Myeloma bone and extra-medullary disease: Role of PET\/CT and other whole-body imaging techniques"],"prefix":"10.1016","volume":"101","author":[{"given":"Giuseppe","family":"Rubini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artor","family":"Niccoli-Asabella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Racanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Maggialetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2016.03.006_bib0005","first-page":"1592","article-title":"18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment","volume":"47","author":"Agool","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0010","first-page":"S50","article-title":"Useful diagnostic biometabolic data obtained by PET\/CT and MR fusion imaging using open source software","volume":"17","author":"Antonica","year":"2014","journal-title":"Hell. J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2141.2007.06639.x","article-title":"Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3","volume":"138","author":"Barlogie","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0020","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2009-03-213280","article-title":"F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma","volume":"114","author":"Bartel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0025","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/cncr.10818","article-title":"Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon","volume":"95","author":"Baur","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0030","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.rcl.2008.05.002","article-title":"Oncohaematologic disorders affecting the skeleton in the elderly","volume":"46","author":"Baur-Melnyk","year":"2008","journal-title":"Radiol. Clin. N. Am."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejrad.2005.01.017","article-title":"Role of MRI for the diagnosis and prognosis of multiple myeloma","volume":"55","author":"Baur-Melnyk","year":"2005","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0040","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2214\/AJR.07.2635","article-title":"Whole-body MRI versus whole-body MDCT for staging of multiple myeloma","volume":"190","author":"Baur-Melnyk","year":"2008","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/snuc.2001.18742","article-title":"Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate","volume":"31","author":"Blake","year":"2001","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0050","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2214\/ajr.184.4.01841199","article-title":"Value of FDG PET in the assessment of patients with multiple myeloma","volume":"184","author":"Bredella","year":"2005","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11547-011-0708-3","article-title":"Whole-body MR-DWIBS vs. [18F]-FDG-PET\/CT in the study of malignant tumors: a retrospective study","volume":"117","author":"Cafagna","year":"2012","journal-title":"Radiol. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0060","first-page":"175803","article-title":"The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to treatment in patients with multiple myeloma","volume":"2012","author":"Caldarella","year":"2012","journal-title":"Int. J. Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1102\/1470-7330.2006.0021","article-title":"Diffusion-weighted magnetic resonance imaging and its application to cancer","volume":"6","author":"Charles-Edwards","year":"2006","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0070","doi-asserted-by":"crossref","first-page":"N10","DOI":"10.1055\/s-0038-1626489","article-title":"Visual and quantitative approach to bone marrow foci of increased glucose uptake on PET\/CT in a case of aplastic anaemia","volume":"49","author":"Cicone","year":"2010","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0075","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1102\/1470-7330.2005.0033","article-title":"Problems monitoring response in multiple myeloma","volume":"5","author":"Collins","year":"2005","journal-title":"Cancer Imaging"},{"issue":"Suppl. 12","key":"10.1016\/j.critrevonc.2016.03.006_bib0080","doi-asserted-by":"crossref","first-page":"S2927","DOI":"10.1002\/1097-0142(20000615)88:12+<2927::AID-CNCR8>3.0.CO;2-V","article-title":"The role of positron emission tomography in the management of bone metastases","volume":"88","author":"Cook","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2141.2007.06491.x","article-title":"Guidelines for the use of imaging in the management of myeloma","volume":"137","author":"D'Sa","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10238-014-0308-3","article-title":"18F-FDG PET\/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders","volume":"15","author":"Dammacco","year":"2015","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0095","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1148\/radiol.2422051980","article-title":"Multiple myeloma: molecular imaging with 11C-Methionine PET\/CT\u2014initial experience","volume":"242","author":"Dankerl","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00330-012-2600-5","article-title":"Comparative diagnostic performance of 18F-FDG PET\/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation","volume":"23","author":"Derlin","year":"2013","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0002-9343(93)90120-E","article-title":"Risk of disease progression in asymptomatic multiple myeloma","volume":"94","author":"Dimopoulos","year":"1993","journal-title":"Am. J. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0110","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood.V96.6.2037","article-title":"Solitary plasmacytoma of bone and asymptomatic multiple myeloma","volume":"96","author":"Dimopoulos","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0115","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","article-title":"Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3","volume":"117","author":"Dimopoulos","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0120","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","article-title":"Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement","volume":"33","author":"Dimopoulos","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0125","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0130","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ejca.2005.11.037","article-title":"The role of anatomic and functional staging in myeloma: description of Durie\/Salmon plus staging system","volume":"42","author":"Durie","year":"2006","journal-title":"Eur. J. Cancer."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0135","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/j.semnuclmed.2007.07.002","article-title":"18F-Fluoride positron emission tomography and positron emission tomography\/computed tomography","volume":"37","author":"Even-Sapir","year":"2007","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0140","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.acra.2010.08.002","article-title":"Response assessment in patients with multiple myeloma during antiangiogenic therapy using arterial spin labeling and diffusion-weighted imaging: a feasibility study","volume":"17","author":"Fenchel","year":"2010","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0145","first-page":"S40","article-title":"Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET\/CT in newly diagnosed lymphoma","volume":"17","author":"Ferrari","year":"2014","journal-title":"Hell. J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2967\/jnumed.107.045641","article-title":"18F-FDG PET\/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma","volume":"49","author":"Fonti","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0155","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2967\/jnumed.112.106500","article-title":"Metabolic tumor volume assessed by 18F-FDG PET\/CT for the prediction of outcome in patients with multiple myeloma","volume":"53","author":"Fonti","year":"2012","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1148\/radiol.2372041741","article-title":"Whole-body CT screening: spectrum of findings and recommendations in 1192 patients","volume":"237","author":"Furtado","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejrad.2005.01.016","article-title":"Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET\/CT for the detection of metastases of bone","volume":"55","author":"Ghanem","year":"2005","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00256-008-0607-4","article-title":"Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI)","volume":"38","author":"Gleeson","year":"2009","journal-title":"Skelet. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2214\/ajr.183.3.1830645","article-title":"Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies: incidence and MRI findings","volume":"183","author":"Hartman","year":"2004","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0180","doi-asserted-by":"crossref","first-page":"583439","DOI":"10.1155\/2011\/583439","article-title":"Multiple myeloma: a review of imaging features and radiological techniques","volume":"2011","author":"Healy","year":"2011","journal-title":"Bone Marrow Res."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejrad.2005.03.031","article-title":"Diffusion weighted imaging of bone marrow pathologies","volume":"55","author":"Herneth","year":"2005","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0190","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3109\/10428194.2012.740559","article-title":"Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging early myeloma","volume":"54","author":"Hillengass","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0195","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/leu.2013.244","article-title":"Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance","volume":"28","author":"Hillengass","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejrad.2004.04.015","article-title":"Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography","volume":"54","author":"Horger","year":"2005","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0205","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/cncr.22572","article-title":"The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma","volume":"109","author":"Horger","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0210","doi-asserted-by":"crossref","first-page":"W790","DOI":"10.2214\/AJR.10.5979","article-title":"Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results","volume":"196","author":"Horger","year":"2011","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0215","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.rct.0000237820.41549.c9","article-title":"Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography","volume":"31","author":"Hur","year":"2007","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0220","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2967\/jnumed.108.058339","article-title":"Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET\/CT scan for evaluation of malignancy: results of the pilot-phase study","volume":"50","author":"Iagaru","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0225","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1007\/s00330-003-1890-z","article-title":"Whole-body turbo STIR MR imaging: controversies and avenues for development","volume":"13","author":"Kavanagh","year":"2003","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0230","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2407-6-118","article-title":"Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study","volume":"6","author":"Knobel","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00330-007-0738-3","article-title":"Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma","volume":"18","author":"Kr\u00f6pil","year":"2008","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0240","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0245","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00277-009-0829-0","article-title":"Role of radiography, MRI and FDG-PET\/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma","volume":"88","author":"L\u00fctje","year":"2009","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0250","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.18632\/oncotarget.2290","article-title":"18 FDG-PET\/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation","volume":"5","author":"Lapa","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1148\/radiology.204.1.9205246","article-title":"Vertebral compression fractures in multiple myeloma. Part I. Distribution and appearance at MR imaging","volume":"204","author":"Lecouvet","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0260","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1148\/radiology.209.3.9844655","article-title":"Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging","volume":"209","author":"Lecouvet","year":"1998","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2001-12920","article-title":"Magnetic resonance and computed tomography imaging in multiple myeloma","volume":"5","author":"Lecouvet","year":"2001","journal-title":"Semin. Musculoskelet. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0270","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00330-010-1758-y","article-title":"Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma","volume":"20","author":"Lin","year":"2010","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0275","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1200\/JCO.2004.00.8581","article-title":"18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes","volume":"23","author":"Mahfouz","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0280","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2214\/ajr.178.6.1781429","article-title":"Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography","volume":"178","author":"Mahnken","year":"2002","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.seminhematol.2010.11.006","article-title":"Molecular imaging in myeloma precursor disease","volume":"48","author":"Mena","year":"2011","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0290","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/leu.2014.75","article-title":"Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma","volume":"28","author":"Merz","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0295","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.28481","article-title":"The effects of bortezomib on bone disease in patients with multiple myeloma","volume":"120","author":"Mohty","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0300","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1148\/radiology.185.3.1438772","article-title":"Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease","volume":"185","author":"Moulopoulos","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0305","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1148\/radiology.193.2.7972760","article-title":"Multiple myeloma: MR patterns of response to treatment","volume":"193","author":"Moulopoulos","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0310","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00259-005-0004-3","article-title":"Role of 18F-FDG PET\/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results","volume":"33","author":"Nanni","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0315","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7819-5-68","article-title":"11C-choline vs 18F-FDG PET\/CT in assessing bone involvement in patients with multiple myeloma","volume":"5","author":"Nanni","year":"2007","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0320","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/RLU.0b013e318266cee2","article-title":"The value of 18F-FDG PET\/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients","volume":"38","author":"Nanni","year":"2013","journal-title":"Clin. Nucl. Med."},{"issue":"October","key":"10.1016\/j.critrevonc.2016.03.006_bib0325","article-title":"Image interpretation criteria for FDG PET\/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe)","volume":"16","author":"Nanni","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0330","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.diii.2013.01.005","article-title":"Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma","volume":"94","author":"Narquin","year":"2013","journal-title":"Diagn. Interv. Imaging"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5603\/NMR.2013.0035","article-title":"18F-FDGPET\/CT: diabetes and hyperglycaemia","volume":"16","author":"Niccoli-Asabella","year":"2013","journal-title":"Nucl. Med. Rev. Cent. East. Eur."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0340","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12185-010-0595-8","article-title":"(11)C-Methionine PET\/CT for multiple myeloma","volume":"91","author":"Nishizawa","year":"2010","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0345","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1158\/1078-0432.CCR-14-2841","article-title":"Grupo Espa\u00f1ol de Mieloma (GEM)\/Programa para el Estudio de la Terap\u00e9utica en Hemopat\u00edas Malignas (PETHEMA) cooperative study groups. Is this the time to introduce minimal residual disease in multiple myeloma clinical practice?","volume":"21","author":"Paiva","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0350","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0355","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbmt.2015.03.001","article-title":"The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation","volume":"21","author":"Patriarca","year":"2015","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0360","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0365","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/leu.2008.336","article-title":"Pathogenesis of myeloma bone disease","volume":"23","author":"Roodman","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0370","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00259-014-2721-y","article-title":"PET\/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics","volume":"41","author":"Sachpekidis","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0375","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3324\/haematol.12654","article-title":"FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma","volume":"93","author":"Salaun","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0380","first-page":"1800","article-title":"Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer","volume":"42","author":"Schirrmeister","year":"2001","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0385","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00259-001-0711-3","article-title":"Initial results in the assessment of multiple myeloma using 18F-FDG PET","volume":"29","author":"Schirrmeister","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0390","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2214\/AJR.08.1633","article-title":"Whole-Body MRI versus PET in assessment of multiple myeloma disease activity","volume":"192","author":"Shortt","year":"2009","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0395","first-page":"2","article-title":"Nuclear medicine in myeloma: the state of the science and emerging trends","volume":"14","author":"Sood","year":"2011","journal-title":"Hell. J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0400","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2214\/ajr.167.4.8819407","article-title":"Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates","volume":"167","author":"St\u00e4bler","year":"1996","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0405","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3109\/10428194.2011.573036","article-title":"Current and future imaging modalities for multiple myeloma and its precursor states","volume":"52","author":"Tan","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0410","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/annonc\/mdi235","article-title":"Myeloma bone disease: pathophysiology and management","volume":"16","author":"Terpos","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0415","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.2014.117176","article-title":"European Myeloma Network guidelines for the management of multiple myeloma-related complications","volume":"100","author":"Terpos","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0420","first-page":"104546","article-title":"Diagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvement","volume":"2013","author":"Tosi","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0425","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood-2012-08-451690","article-title":"Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3","volume":"121","author":"Usmani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0430","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1148\/radiology.202.1.8988218","article-title":"Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome","volume":"202","author":"Vande Berg","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0435","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0440","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1200\/JCO.2006.08.5803","article-title":"Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications","volume":"25","author":"Walker","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0445","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejrad.2007.10.025","article-title":"Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns","volume":"69","author":"Weininger","year":"2009","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0450","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/bjh.12007","article-title":"The role of imaging techniques in the management of multiple myeloma","volume":"159","author":"Zamagni","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0455","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.10554","article-title":"A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma","volume":"92","author":"Zamagni","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0460","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1182\/blood-2011-06-361386","article-title":"Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation","volume":"118","author":"Zamagni","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0465","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1158\/1078-0432.CCR-15-0396","article-title":"PET\/CT improves the definition of complete response and allows to detect otherwise unidentifiable skeletal progression in multiple myeloma","volume":"21","author":"Zamagni","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.03.006_bib0470","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/leu.2015.291","article-title":"18F-FDG PET\/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease","volume":"30","author":"Zamagni","year":"2016","journal-title":"Leukemia"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084281630049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084281630049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T20:25:44Z","timestamp":1718396744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084281630049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":94,"alternative-id":["S104084281630049X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.03.006","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloma bone and extra-medullary disease: Role of PET\/CT and other whole-body imaging techniques","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}